This would help explain how PTPN22 could influence risk of diverse autoimmune diseases such as type 1 diabetes and rheumatoid arthritis, diseases with distinct ages of onset and tissue targets. This evidence concerns the gene PTPN22 and type 1 diabetes mellitus.